Atlas Trials

RedHill Biopharma Limited

19 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch RedHill Biopharma Limited

RecordFirmDate
Evaluate Safety and Efficacy of Rifamycin SV MMX in the Treatment of Traveler's Diarrhea in Children Age 6 to 11 Years (NCT04026984)RedHill Biopharma Limited2024-06-01
Study to Evaluate Safety and Efficacy of Rifamycin SV MMX in Treating Traveler's Diarrhea in Children Age 12 to 17 Years (NCT04027894)RedHill Biopharma Limited2024-01-01
Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease (NCT04723537)RedHill Biopharma Limited2021-02-16
RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex Disease (NCT04616924)RedHill Biopharma Limited2020-12-01
Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia (NCT04467840)RedHill Biopharma Limited2020-08-21
Treatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring Oxygen (NCT04502069)RedHill Biopharma Limited2020-08-01
A Study of Opaganib in Coronavirus Disease 2019 Pneumonia (NCT04414618)RedHill Biopharma Limited2020-07-02
A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma (NCT03377179)RedHill Biopharma Limited2018-03-07

Track RedHill Biopharma Limited automatically

Every clearance here is in the API, with alerts when new ones post.